Urokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix.

[1]  A. Vaheri,et al.  Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants , 1989, The Journal of cell biology.

[2]  M. Scully,et al.  Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. , 1989, The Journal of biological chemistry.

[3]  K. Bendtzen.  Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity. , 1988, Immunology letters.

[4]  J. Plescia,et al.  Plasminogen receptors, urokinase receptors, and their modulation on human endothelial cells. , 1988, Blood.

[5]  V Ottevanger,et al.  Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo. , 1988, The Journal of investigative dermatology.

[6]  M. Gimbrone,et al.  Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. , 1988, The Journal of biological chemistry.

[7]  F. Blasi.  Surface Receptors for Urokinase Plasminogen Activator , 1988 .

[8]  K. Danø,et al.  Immunohistochemical localization of urokinase-type plasminogen activator in Sertoli cells and tissue-type plasminogen activator in spermatogenic cells in the rat seminiferous epithelium. , 1988, Developmental biology.

[9]  F. Blasi,et al.  A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification. , 1988, The Journal of biological chemistry.

[10]  W. Fiers,et al.  48 Induction of u-PA antigen and mRNA in human endothelial cells by inflammatory mediators , 1988 .

[11]  J. Nielsen,et al.  Tissue-type plasminogen activator in somatostatin cells of rat pancreas and hypothalamus. , 1987, Endocrinology.

[12]  L. Orci,et al.  Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells , 1987, The Journal of cell biology.

[13]  T. Kooistra,et al.  Production of Plasminogen Activators and Inhibitor by Serially Propagated Endothelial Cells from Adult Human Blood Vessels , 1987, Arteriosclerosis.

[14]  F. Blasi,et al.  Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors , 1987, The Journal of cell biology.

[15]  K. Danø,et al.  Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin. , 1987, The Journal of investigative dermatology.

[16]  P. Andreasen,et al.  Plasminogen activator in psoriatic scales is of the tissue‐type PA as identified by monoclonal antibodies , 1985, The British journal of dermatology.

[17]  K. Danø,et al.  Immunocytochemical demonstration of tissue-type plasminogen activator in endocrine cells of the rat pituitary gland , 1985, The Journal of cell biology.

[18]  D. Belin,et al.  A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase , 1985, The Journal of cell biology.

[19]  K. Danø,et al.  Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.

[20]  S. Thorsen,et al.  Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex. , 1984, Biochimica et biophysica acta.

[21]  K. Danø,et al.  immunocytochemical localization of urokinase-type plasminogen activator in lewis lung carcinoma , 1984, The Journal of cell biology.

[22]  K. Danø,et al.  Human endothelial cells contain one type of plasminogen activator , 1984, FEBS letters.

[23]  K. Danø,et al.  Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse , 1984, The Journal of cell biology.

[24]  S. Müllertz.  Fibrinolysis: An Overview , 1984, Seminars in thrombosis and hemostasis.

[25]  E. Levin.  Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D. Loskutoff,et al.  Cultured bovine endothelial cells produce both urokinase and tissue- type plasminogen activators , 1982, The Journal of cell biology.

[27]  J. Zeuthen,et al.  Monoclonal antibody that specifically inhibits a human Mr 52,000 plasminogen-activating enzyme. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[28]  G. Osikowicz,et al.  Immunological identification and comparison of plasminogen activator forms in cultured normal human endothelial cells and smooth muscle cells. , 1981, Thrombosis research.

[29]  D. Collen.  On the Regulation and Control of Fibrinolysis , 1980, Thrombosis and Haemostasis.

[30]  D. Rijken,et al.  Relationship between tissue plasminogen activator and the activators in blood and vascular wall. , 1980, Thrombosis research.

[31]  L. Ossowski,et al.  Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue , 1979, Cell.

[32]  E. Reich.  ACTIVATION OF PLASMINOGEN: A GENERAL MECHANISM FOR PRODUCING LOCALIZED EXTRACELLULAR PROTEOLYSIS , 1978 .

[33]  V. Marchesi,et al.  The migration of lymphocytes through the endothelium of venules in lymph nodes: an electron microscope study , 1964, Proceedings of the Royal Society of London. Series B. Biological Sciences.